Ana
Vega Gliemmo
University of Rome Tor Vergata
Roma, ItaliaPublicacións en colaboración con investigadores/as de University of Rome Tor Vergata (1)
2018
-
Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and breast/ovarian) cancer susceptibility genes: An international survey by the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) clinical working group
JCO Precision Oncology, Vol. 2